GlassScriptPhysician profile
Peter J Sunenshine
NPI 1487610937
$50,978.40
in general payments reported to CMS, 2019-2025
28 companies · $16K in 2025
The $16K reported for 2025 was more than what 89% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,185 · 2020: $27K · 2021: $1,839 · 2022: $969 · 2023: $902 · 2024: $580 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,120.00 |
| Food and Beverage | $1,989.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $28,594.67 | 2019-2020 | |
| Single Pass INC | $15,120.00 | 2025 | Kronos |
| Imperative Care, INC | $2,010.77 | 2020-2025 | Zoom 88-T Large Distal Platform |
| Penumbra, INC. | $892.93 | 2020-2025 | Red 72, Penumbra System, Benchmark |
| Depuy Synthes Sales INC. | $709.84 | 2019-2025 | Cerepak Uniform, N/A |
| Medtronic, INC. | $581.61 | 2021-2025 | Solitaire X, Spiderfx, Protege Rx |
| Stryker Corporation | $489.59 | 2019-2020 | |
| Microvention, INC. | $488.63 | 2019-2022 | |
| Route 92 Medical, INC. | $334.71 | 2023-2025 | 8f Base Camp Sheath System |
| Relievant Medsystems, INC. | $326.39 | 2020-2021 | |
| Balt USA, LLC | $307.66 | 2021-2022 | |
| Rapid Medical LTD | $294.60 | 2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Phenox INC. | $199.80 | 2022 | |
| Allergan, INC. | $181.36 | 2019-2020 | |
| Okami Medical, INC. | $69.45 | 2024 | Lobo |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $57.52 | 2022-2024 | Vumerity, Tysabri |
| Bard Peripheral Vascular, INC. | $45.20 | 2021 | |
| Mallinckrodt Enterprises LLC | $42.58 | 2019 | |
| Eisai INC. | $35.87 | 2019 | |
| Biosense Webster, INC. | $34.84 | 2019 | |
| Terumo Medical Corporation | $29.79 | 2019 | |
| Abbott Laboratories | $29.14 | 2023 | |
| Neurocrine Biosciences, INC. | $24.99 | 2024 | Ingrezza |
| Siemens Medical Solutions USA, INC. | $23.62 | 2022 | |
| Ekos Corporation | $13.61 | 2019 | |
| Ethicon US, LLC | $13.58 | 2021 | |
| Boston Scientific Corporation | $13.40 | 2019 | |
| Cardinal Health 200 LLC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sunenshine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.